Sandra Liekens

6.5k total citations · 1 hit paper
141 papers, 5.2k citations indexed

About

Sandra Liekens is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Sandra Liekens has authored 141 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 47 papers in Organic Chemistry and 38 papers in Oncology. Recurrent topics in Sandra Liekens's work include Synthesis and biological activity (28 papers), Click Chemistry and Applications (18 papers) and Biochemical and Molecular Research (17 papers). Sandra Liekens is often cited by papers focused on Synthesis and biological activity (28 papers), Click Chemistry and Applications (18 papers) and Biochemical and Molecular Research (17 papers). Sandra Liekens collaborates with scholars based in Belgium, Italy and Spain. Sandra Liekens's co-authors include Erik De Clercq, Johan Neyts, Jan Balzarini, María‐Jesús Pérez‐Pérez, Annelies Bronckaers, Sofie Struyf, Dominique Schols, Sam Noppen, Jan Balzarini and Sigrid Hatse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Sandra Liekens

141 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiogenesis: regulators and clinical applications

2001 589 citations Sandra Liekens, Erik De Clercq et al. Biochemical Pharmacology profile →

Peers

Countries citing papers authored by Sandra Liekens

Since Specialization

Citations

This map shows the geographic impact of Sandra Liekens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Liekens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Liekens more than expected).

Fields of papers citing papers by Sandra Liekens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Liekens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Liekens. The network helps show where Sandra Liekens may publish in the future.

Co-authorship network of co-authors of Sandra Liekens

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Liekens. A scholar is included among the top collaborators of Sandra Liekens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Liekens. Sandra Liekens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3′,4′,5′-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold 2020 ·Molecules ·Romeo Romagnoli, Filippo Prencipe, Paola Oliva, Barbara Cacciari, Jan Balzarini, Sandra Liekens, Ernest Hamel, Andrea Brancale, Salvatore Ferla, Stefano Manfredini, (unknown), Alessia Finotti, Roberto Gambari	13
2	Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity 2018 ·Frontiers in Immunology ·Rik Janssens, Daiane Boff, Pieter Ruytinx, Anneleen Mortier, Vincent Vanheule, Olav Larsen, (unknown), Mette M. Rosenkilde, Sam Noppen, Sandra Liekens, Dominique Schols, Ingrid De Meester, Ghislain Opdenakker, Sofie Struyf, Mauro Martins Teixeira, Flávio A. Amaral, Paul Proost	6
3	CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer 2018 ·Experimental Cell Research ·Mohammed Benkheil, Matthias Van Haele, Tania Roskams, Manon Laporte, Sam Noppen, (unknown), Leen Delang, Johan Neyts, Sandra Liekens	41
4	Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses 2017 ·Biochemical Pharmacology ·Jan Balzarini, (unknown), Kalyan Das, (unknown), Alan Ford, (unknown), Sandra Liekens, Paul E. Boehmer, Eddy Arnold, Matthias Götte, Anita R. Maguire	10
5	Design, Synthesis and Evaluation of Antiproliferative Activity of New Benzimidazolehydrazones 2016 ·Molecules ·Valentina Onnis, Monica Demurtas, Alessandro Deplano, Gianfranco Balboni, Anna Baldisserotto, Stefano Manfredini, Salvatore Pacifico, Sandra Liekens, Jan Balzarini	34
6	High mannose-specific lectin Msl mediates key interactions of the vaginal Lactobacillus plantarum isolate CMPG5300 2016 ·Scientific Reports ·Shweta Malik, Mariya Petrova, Nicole C. E. Imholz, Tine Verhoeven, Sam Noppen, Els J. M. Van Damme, Sandra Liekens, Jan Balzarini, Dominique Schols, Jos Vanderleyden, Sarah Lebeer	27
7	Carbohydrate-Binding Non-Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine Models 2016 ·PLoS Pathogens ·(unknown), Luis M. Ruiz‐Pérez, Juan Etxebarria, Niels C. Reichardt, Miguel Navarro, Yasuhiro Igarashi, Sandra Liekens, Jan Balzarini, Dolores González‐Pacanowska	15
8	Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1- b ][1,3,4]thiadiazole and imidazo[2,1- b ][1,3]thiazole scaffolds 2015 ·European Journal of Medicinal Chemistry ·Romeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, Jan Balzarini, Sandra Liekens, Francisco Estévez	51
9	Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine 2014 ·Journal of Biological Chemistry ·Johan Vande Voorde, Suna Sabuncuoğlu, Sam Noppen, Anders Hofer, Farahnaz Ranjbarian, Steffen Fieuws, Jan Balzarini, Sandra Liekens	125
10	Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III 2013 ·PLoS ONE ·(unknown), Marijke Alen, Sam Noppen, Dominique Schols, Pasqua Oreste, Sandra Liekens	33
11	A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity 2013 ·PLoS Pathogens ·Jan Balzarini, Graciela Andreï, E Balestra, Dana Huskens, Christophe Vanpouille, Andrea Introini, Sonia Zicari, Sandra Liekens, Robert Snoeck, Antonı́n Holý, Carlo Federico Perno, Leonid Margolis, Dominique Schols	20
12	Inhibition of pyrimidine and purine nucleoside phosphorylases by a 3,5-dichlorobenzoyl-substituted 2-deoxy-d-ribose-1-phosphate derivative 2012 ·Biochemical Pharmacology ·Johan Vande Voorde, Maurizio Quintiliani, Christopher McGuigan, Sandra Liekens, Jan Balzarini	7
13	Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function 2011 ·International Journal of Cancer ·Heléne Piccard, Nele Berghmans, Éva Korpos, Chris Dillen, Ilse Van Aelst, Sandra Li, Erik Martens, Sandra Liekens, Sam Noppen, Jo Van Damme, Lydia Sorokin, Ghislain Opdenakker	8
14	Novel pyrazole derivatives: Synthesis and evaluation of anti-angiogenic activity 2010 ·Bioorganic & Medicinal Chemistry ·Michael S. Christodoulou, Sandra Liekens, Konstantinos M. Kasiotis, Serkos A. Haroutounian	107
15	Human Mitochondrial Thymidine Kinase Is Selectively Inhibited by 3′-Thiourea Derivatives of β-Thymidine: Identification of Residues Crucial for Both Inhibition and Catalytic Activity 2009 ·Molecular Pharmacology ·Jan Balzarini, (unknown), Ana Negri, Nicola Solaroli, Anna Karlsson, Sandra Liekens, Federico Gago, Serge Van Calenbergh	9
16	The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy 2008 ·Biochemical Pharmacology ·Annelies Bronckaers, Jan Balzarini, Sandra Liekens	57
17	5‘-O-Tritylinosine and Analogues as Allosteric Inhibitors of Human Thymidine Phosphorylase 2006 ·Journal of Medicinal Chemistry ·Elena Casanova, Ana Isabel Hernández, Eva‐María Priego, Sandra Liekens, Marı́a-José Camarasa, Jan Balzarini, María‐Jesús Pérez‐Pérez	34
18	Potent inhibition of hemangiosarcoma development in mice by cidofovir 2001 ·International Journal of Cancer ·Sandra Liekens, Erik Verbeken, Erik De Clercq, Johan Neyts	24
19	Effect of TNP-470 (AGM-1470) on the Growth of Rat Rhabdomyosarcoma Tumors of Different Sizes 2001 ·Cancer Investigation ·Willy Landuyt, Jan Theys, Sandra Nuyts, M. Drijkoningen, Jack Fowler, (unknown), Sandra Liekens, Johan Neyts, Ernst de Bruijn, Jozef Anné, Philippe Lambin	2
20	7‐Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase 1998 ·FEBS Letters ·Jan Balzarini, (unknown), Robert Esnouf, Sandra Liekens, Johan Neyts, Erik De Clercq, Marı́a-José Camarasa, María‐Jesús Pérez‐Pérez	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact